29 completed. 29 Phase 2, 6 Phase 1, 4 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 29 | Completed 29 |
| Phase 1 | 6 | Completed 6 |
| Phase 3 | 4 | Completed 4 |
Follow Nephrolithiasis: new trials by email Literature Review of Nephrolithiasis trials Research Report on Nephrolithiasis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase 2a Study of LLX-424 in Patients With a History of Kidney Stones LLX-424 - Kidney Stones | Phase 2 | Completed | Lilac Therapeutics, Inc. | 51 | 2025-03-23 | 2025-10-29 |
| Flexible Mini Percutaneous Nephrolithotomy Vs Retrograde Intra-renal Surgery flexible mini percutaneous nephrolithotomy, Retrograde intrarenal surgery - Renal Stone | Phase 2 / Phase 3 | Completed | Ain Shams University | 130 | 2024-01-01 | 2024-10-29 |
| Erector Spinae Plane Block for Uncomplicated Renal Colic Erector Spinae Plane Block (ESPB), Ropivacaine - Renal Colic, Kidney Stone | Phase 2 | Completed | University of Michigan | 5 | 2023-02-08 | 2025-10-30 |
| Silodosin in Management of Lower Ureteral Stones Silodosin - Stone, Kidney | Phase 1 / Phase 2 | Completed | Syrian Private University | 100 | 2022-10-20 | 2024-04-24 |
| Impact of the SGLT2 Inhibitor Empagliflozin on Urinary Supersaturations in Kidney Stone Formers Empagliflozin 25 MG, Placebo - Kidney Stone | Phase 2 | Completed | Insel Gruppe AG, University Hospital Bern | 50 | 2021-08-25 | 2023-05-12 |
| Effect of Antihistamines on Ureteral Stent-Related Symptoms Fexofenadine Hcl 180Mg Tab, Placebo - Nephrolithiasis | Phase 2 | Completed | Columbia University | 78 | 2021-06-29 | 2025-07-16 |
| Multicenter, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Fluconazole in Hypercalcicuric Patients With Increased 1.25(OH) 2D Levels Fluconazole, Placebo - Nephrolithiasis, Nephrocalcinosis | Phase 2 | Completed | Hospices Civils de Lyon | 56 | 2021-01-13 | 2024-07-12 |
| Perioperative Pregabalin in Ureteroscopy Pregabalin 300mg, Placebo oral tablet - Kidney Stone, Pain, Postoperative | Phase 2 / Phase 3 | Completed | University of Missouri-Columbia | 118 | 2020-06-01 | 2025-11-12 |
| Pramipexole and Morphine for Renal Colic Pramipexole, Morphine, Placebo oral tablet - Renal Colic | Phase 1 / Phase 2 | Completed | East Carolina University | 19 | 2019-10-28 | 2023-03-08 |
| Efficacy and Safety of Renalof® in the Removal of Calculi Smaller Than 10 mm Located in the Reno-Ureteral Tract Renalof, Placebo - Renal Injury, Kidney Injury | Phase 2 | Completed | Catalysis SL | 155 | 2019-08-01 | 2021-01-06 |
| Supine Percutaneous Nephrolithotomy percutaneous nephrolithotomy (supine position), percutaneous nephrolithotomy ( prone position) - Renal Stone | Phase 2 / Phase 3 | Completed | Ain Shams University | 70 | 2019-06-01 | 2022-07-14 |
| Study of ALLN-177 in Patients Aged 12 Years or Older With Enteric or Primary Hyperoxaluria and Hyperoxalemia ALLN-177 - Enteric Hyperoxaluria, Primary Hyperoxaluria | Phase 2 | Completed | Allena Pharmaceuticals | 15 | 2018-07-17 | 2020-12-30 |
| Prospective Randomized Controlled Trial for Pain Relief After Office Ureteral Stent Removal Ketorolac, normal saline - Pain, Urinary Stone | Phase 2 | Completed | University of Texas Southwestern Medical Center | 125 | 2018-06-28 | 2024-01-10 |
| Toradol to Reduce Ureteroscopic Symptoms Trial Toradol - Urinary Lithiasis, Kidney Diseases | Phase 2 | Completed | Yale University | 94 | 2017-08-01 | 2021-11-02 |
| Lipoic Acid Supplement for Cystine Stone Alpha lipoic acid, Placebo - Cystinuria | Phase 2 | Completed | Thomas Chi, MD | 50 | 2017-06-19 | 2026-04-15 |
| Evaluate the Effect of ALLN-177 in Reducing Urinary Oxalate in Patients With Secondary Hyperoxaluria and Kidney Stones Over 28 Days ALLN-177, Placebo - Secondary Hyperoxaluria, Nephrolithiasis | Phase 2 | Completed | Allena Pharmaceuticals | 66 | 2015-09-01 | 2017-01-19 |
| Evaluate the Effect of ALLN-177 in Reducing Urinary Oxalate in Patients With Hyperoxaluria and Kidney Stones ALLN-177 low dose, ALLN-177 mid dose, ALLN-177 high dose - Secondary Hyperoxaluria, Nephrolithiasis | Phase 2 | Completed | Allena Pharmaceuticals | 32 | 2015-07-01 | 2018-01-11 |
| Comparing Pneumatic Versus Ultra-sonic Percutaneous Nephrolithotomy in Large Kidney Stones Pneumatic percutaneous nephrolithotomy, Ultra-sonic percutaneous nephrolithotomy - Kidney Stone | Phase 2 | Completed | Isfahan University of Medical Sciences | 180 | 2014-12-01 | 2016-04-26 |
| Evaluating ALLN-177 for Reducing Urinary Oxalate Excretion in Calcium Oxalate Kidney Stone Formers With Hyperoxaluria ALLN-177 - Hyperoxaluria, Nephrolithiasis | Phase 2 | Completed | Allena Pharmaceuticals | 16 | 2014-09-01 | 2019-06-05 |
| Treatment for Calcium Phosphate Kidney Stone Disease Placebo, Citric Acid, Potassium Citrate - Calcium Phosphate Kidney Stones | Phase 2 | Completed | University of Texas Southwestern Medical Center | 13 | 2012-07-01 | 2024-04-04 |
Showing 20 of 29. Sign in to see all of them.
Kidney Calculi (24) · Kidney Diseases (5) · Urolithiasis (5) · Hyperoxaluria (4) · Renal Colic (3) · Urologic Diseases (3) · Calculi (2) · Cystinuria (2) · Hypercalciuria (2) · Nephrolithiasis, Calcium Oxalate (2) · Pain, Postoperative (2) · Ureteral Calculi (2) · Ureteral Obstruction (2) · Urinary Calculi (2)
Female Urogenital Diseases (29) · Female Urogenital Diseases and Pregnancy Complications (29) · Male Urogenital Diseases (29) · Urogenital Diseases (29) · Urologic Diseases (26) · Pathological Conditions, Signs and Symptoms (25) · Kidney Diseases (24) · Pathological Conditions, Anatomical (24) · Urolithiasis (24) · Calculi (22) · Urinary Calculi (22) · Signs and Symptoms (8) · Neurologic Manifestations (6) · Pain (5)
oxalate decarboxylase (4) · reloxaliase (4) · Ketorolac Tromethamine (2) · silodosin (2) · Allopurinol (1) · Citric Acid (1) · Febuxostat (1) · Fluconazole (1) · Isoproterenol (1) · Ketorolac (1) · Morphine (1) · Nephrolithotomy, Percutaneous (1) · Potassium Citrate (1) · Pramipexole (1) · Pregabalin (1)
Allena Pharmaceuticals (4) · Ain Shams University (2) · Mayo Clinic (2) · University of Texas Southwestern Medical Center (2) · Catalysis SL (1) · Columbia University (1) · East Carolina University (1) · Fredericia Hosptial (1) · Hospices Civils de Lyon (1) · Insel Gruppe AG, University Hospital Bern (1) · Isfahan University of Medical Sciences (1) · Lilac Therapeutics, Inc. (1) · London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's (1) · Mario Negri Institute for Pharmacological Research (1) · Omeros Corporation (1)
United States (18) · Egypt (2) · Canada (1) · Denmark (1) · France (1) · Germany (1) · Iran (1) · Italy (1) · Nicaragua (1) · Switzerland (1) · Syria (1) · United Kingdom (1)
Annamaria Kausz, MD MS (2) · Chris Fung (1) · Daniel Fuster, MD (1) · David Clark, MD (1) · Jamshid Roozbeh, MD (1) · John C Lieske, MD (1) · John D Denstedt, MD, FRCSC (1) · Katie Murray, DO (1) · Kori Brewer, PhD (1) · Lee Brettman, MD, FACP (1) · Margaret Pearle, MD.PhD (1) · Naim M Maalouf, MD (1) · Nasser Simforoosh, Prof (1) · Ojas Shah, MD (1)
PMID 20736987, PMID 21161651, PMID 21419606, PMID 23929928, PMID 30783888, PMID 34569278, PMID 35288397, PMID 35710560, PMID 39411383, PMID 39747681, PMID 39937815
P50DK083007 (2), 2017 (1), P20DK100863 (1), R21AT002534 (1), R21DK097476 (1), UL1RR024150 (1)